Posted by Robert Lorsch | Filed under Posts by Robert Lorsch
It’s been a busy couple of months since I have had the time to add to the pages of my blog. However, this last weekend was so relevant to science and technology, and in particular the future of health care (and MMRGlobal) in Japan, that I felt remiss not sharing it on this page. The visit was arranged by U.S. Congressman Dana Rohrabacher who, after welcoming The Honorable Ichita Yamamoto, who is Japan’s Minister of State for Science, Space & Information Technology including Ocean Policy, and his delegation at SpaceX, beamed himself back to Washington for emergency budget resolution votes late Saturday night. As a result I was left hosting the Minister around the Southern California scientific hot spots.
The Minister also happens to be a former rock singer, speaks great English and is an all-around easygoing, quite likable guy.
I first met Minister Yamamoto and his entourage of ten plus drivers and luggage handlers at LAX and joined his State Department Motorcade caravanning to SpaceX for a private briefing and tour of the rocket manufacturing facility, less than twenty hours prior to the launch of Falcon 9 www.spacex.com.
From there, I traveled with the Japanese contingentto the California Science Center where President & CEO Jeffrey Rudolph and Trustee Kira Lorsch greeted us all at the Robert H. Lorsch Family Pavilion.
During our tour of the Science Center, we spent time discussing the effect of natural disasters on the environment in the wake of the recent earthquake and Tsunami in Japan, focusing in particular on the effect of the Fukushima Nuclear Power Plant on the Pacific Oceans. We discussed the U.S. government and Japan scheduling a conference of nations who share coastlines to help mitigate damage from future disasters.
We ended the tour under the wing of Space Shuttle Endeavour where we spoke about how our nations have been working together in space as we looked at a plaque from a U.S.-Japan mission to the Space Station. After the tour everyone enjoyed a luncheon hosted by MMRGlobal, starting with, of course, a traditional Miso soup.
We left the California Science Center and moved on to Aeroscraft located in a 500,000 square foot Marine Corps enclosed Air Station where we sat in the control pod of a state-of-the-art blimp being designed for surveillance and to carry as much as 500,000 tons of cargo as far as 12,000 nautical miles, http://www.huffingtonpost.com/2013/01/07/aeroscraft-test-ground-flight-airship_n_2424916.html.
After a briefing at Aeroscraft we moved to the Orange County Water District (OCWD) where we were hosted by Mr. Linden Blue, father of the Predator Drone amongst other very impressive technology,
There we saw the future of the Nuclear Reactor, small enough to be located on a flatbed truck. After the General Atomics nuclear reactor presentation, http://www.ga.com/nuclear-energy, we toured 30,000 acres of ground water reclamation facilities where we all got to drink sewer water reclaimed to clean drinking water.
The Groundwater Replenishment System technology seems to work, as I’m not sick. The day was capped off by another fabulous meal hosted by OCWD board President Shawn Dewane, where we toasted our future with the Japanese over two excellent California wines, without the reclaimed sewer water.
As MMR expands its global footprint which includes the U.S., Canada, Mexico, Australia, New Zealand, Israel, South Korea, European Nations, China, Hong Kong, Singapore and of course Japan, the whirlwind day underscored the importance of advancing technology in all areas, including healthcare – to make our world a better place.
Robert H. “Bob” Lorsch, CEO, MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010
Follow me on Twitter at BobLorschTweets
Posted by Robert Lorsch | Filed under Posts by Robert Lorsch
Last week, I was in Washington, DC as CEO of MMRGlobal briefing the Congressional Oversight Subcommittee of the House Science, Space, and Technology Committee about my concerns on how eleven billion dollars and counting is being spent under the government’s EHR Incentive Programs. The monies are being spent in spite of the widely known fact that there is no interoperability and hardly any ability to create a comprehensive online personal health record, two items that were mandated as part of Executive Orders and other requirements to provide electronic medical records and personal health records (PHRs) to Americans by 2014. Of course, by being there I also hoped to have the opportunity to draw attention to the fact that MyMedicalRecords is already delivering interoperability and a comprehensive PHR now….today.
During my visit, I was asked by Congressman Dana Rohrabacher to lend my marketing expertise to help raise awareness to the plight of Dr. Afridi. My first question was, “Who is Dr. Afridi?” Then I quickly learned what I did not know, that Dr. Shakil Afridi is the man who pinpointed the location of Osama bin Laden for the United States. Without Dr. Afridi, the United States may not have found Osama bin Laden. His reward was to be abandoned and left behind in a Pakistan prison, reportedly being regularly tortured, and sentenced to live side-by-side with the militants who continue killing our American soldiers. I was shocked and I knew that something had to be done. I never thought that America would leave a hero behind.
The following is a copy of a news release that is being issued from MMRGlobal today. It explains in greater detail what I did in Washington and how those meetings led to Kira and me calling on Oscar® to help FREE AFRIDI.
If you believe, like Kira and I do, that this man deserves our combined voice to be released and regain his freedom, then visit www.freeafridi.com, read the Letter from Congressman Rohrabacher, and do what you can to help bring this great American hero to where he belongs in America. Kira and I will be doing our part on The Red Carpet events throughout the weekend and on news broadcasts wherever we can similar to the one on CBS that is here: http://losangeles.cbslocal.com/2013/02/20/can-zero-dark-thirty-oscars-help-free-imprisoned-doctor-who-helped-find-bin-laden.
FOR IMMEDIATE RELEASE
MMRGlobal CEO Briefs Congressional Oversight Subcommittee on Questions Surrounding Better Ways to Have Spent $11 Billion on HIT Incentives
Los Angeles, CA (February 22, 2013) – Robert H. Lorsch, Chairman and CEO of MMRGlobal, Inc. (OTCQB: MMRF) (“MMR”), a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and MMRPro document management and imaging systems for healthcare professionals, recently met with U.S. Congressional Representatives along with their staffs and the staff of the Subcommittee on Oversight of the House Committee on Science, Space, and Technology. The purpose of the meeting was to brief Representatives and staff on an independent compilation of articles, blogs, reports and opinions pertaining to questions surrounding the payments of nearly $11 billion in stimulus monies under the government’s EHR and Meaningful Use incentive programs. The meeting was also intended to address concerns that primary requirements set forth in federal legislation pertaining to the provisioning of Electronic Health Records (EHRs) were not being met, specifically those which pertain to standardization, interoperability and requirements that most Americans have access to all their protected personal health information through some type of secure Personal Health Record similar to existing offerings from MMR.
According to Lorsch, “After the briefing portion of my presentation, I was able to demonstrate to staff the MyMedicalRecords Personal Health Record and explain how it could be deployed to everyone in America at an annual cost that would be less than the cost of one EMR system in a large hospital. At that time, I had no idea that the points raised in my presentation would become Page One of The New York Times the following Wednesday, less than one week later.” (http://www.nytimes.com/2013/02/20/business/a-digital-shift-on-health-data-swells-profits.html?_r=0)
While in Washington, Lorsch was also asked to attend a meeting with Representative Dana Rohrabacher regarding the plight of Dr. Shakil Afridi, the Pakistani physician that verified Osama bin Laden’s location for the United States. Today, Dr. Afridi is in a Pakistan prison sentenced to 33 years, abandoned, and reportedly being tortured. As a result of that meeting, Lorsch began a campaign, launched in a Special Oscars® issue of The Hollywood Reporter today, and at www.FreeAfridi.com. The campaign appeals for the release of Dr. Afridi by asking that the celebrities attending the Oscars® share a moment of their limelight to help draw attention to America’s abandoned hero.
“After making numerous presentations on behalf of MyMedicalRecords, where I requested support for PHRs, this was the first time that I left Washington believing that the value of a cost-effective, patient-controlled Personal Health Record was being embraced. That includes previous meetings and presentations to former HHS Secretary Mike Leavitt and Homeland Security Secretary Tom Ridge, as well as Congressional Representatives including senior staff members in the office of The Honorable Ted Kennedy, as well as ONC staff and National Coordinators for Health IT David J. Brailer, M.D. and David Blumenthal, M.D.,” Lorsch added.
The briefing also emphasized the point that without standardization, the current HIT infrastructure did not allow a level playing field for small businesses competing with larger health IT equipment and system providers who dominate more than two-thirds of the marketplace. Information included in the briefing also covered how contractual terms from larger EMR systems are written to discourage hospitals from using other vendors which is counter to requirements of standardization and interoperability.
MMR’s technology specifically addresses the issues of interoperability while provisioning a comprehensive Personal Health Record to the patient. The Company offers solutions for patients, physicians and hospitals that seamlessly connect along the lines of the government’s stated goal of interoperability and empowering patients, providing access to their health information in a PHR. MMRGlobal also has an extensive healthcare IT patent portfolio, which includes seven U.S. patents: Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240. The MMR Patent Portfolio includes nearly 400 claims as well as additional applications and continuation applications. The patents involve inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. MMR also has been granted patents and has other pending applications in countries of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, South Korea, Israel, and European nations.
Robert H. “Bob” Lorsch, CEO, MMRGlobal
4401 Wilshire Blvd., 2nd Floor, Los Angeles, CA 90010, Tel. 310-476-7002
All statements in this press release that are not strictly historical in nature, including, without limitation, intellectual property enforcement actions, infringement claims or litigation, intellectual property licenses, and future performance, management’s expectations, beliefs, intentions, estimates or projections, constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “potential,” “intend,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, sources, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company’s health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk the Company’s products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market’s acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations including the 2009 HITECH Act and changes in Meaningful Use and the 2010 Affordable Care Act; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company’s filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Tags: afridi, Bob Lorsch, Dana Rohrabacher, Dr Afridi, EHR, free afridi, HIT, Kira Lorsch, Kira Reed, Lorsch, MMR, mmrf, MMRGlobal, MyESafeDepositBox, Osama Bin Laden, Oscar, Personal Health Records, PHR